Dan Grossman
Directeur/Membre du Conseil chez Lyric Opera of Chicago
Profil
Dan Grossman is currently a Director at Lyric Opera of Chicago and a Managing Director & Senior Partner at The Boston Consulting Group.
He also recently started a new job as a Director at Lykos Therapeutics, Inc. Dr. Grossman holds a doctorate degree from Princeton University and an undergraduate degree from Harvard College.
Postes actifs de Dan Grossman
| Sociétés | Poste | Début |
|---|---|---|
Lyric Opera of Chicago
 Lyric Opera of Chicago Movies/EntertainmentConsumer Services Lyric Opera of Chicago provides live theatrical presentations. The company was founded by Carol Fox, Nicola Rescigno and Lawrence V. Kelly in 1954 and is headquartered in Chicago, IL. | Directeur/Membre du Conseil | - |
Lykos Therapeutics PBC
 Lykos Therapeutics PBC BiotechnologyHealth Technology Part of Multidisciplinary Association for Psychedelic Studies, Lykos Therapeutics, Inc. is a public benefit corporation that focuses on developing and commercializing prescription psychedelics to provide better treatments for people with mental health conditions. The private company is based in San Jose, CA. Lykos Therapeutics aims to catalyze healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics, prioritizing public benefit above profit. The company was founded in 2014, and the CEO is Amy Emerson. | Directeur/Membre du Conseil | 07/06/2022 |
| The Boston Consulting Group | Corporate Officer/Principal | - |
Formation de Dan Grossman
| Princeton University | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Lyric Opera of Chicago
Lyric Opera of Chicago Movies/EntertainmentConsumer Services Lyric Opera of Chicago provides live theatrical presentations. The company was founded by Carol Fox, Nicola Rescigno and Lawrence V. Kelly in 1954 and is headquartered in Chicago, IL. | Consumer Services |
Lykos Therapeutics PBC
Lykos Therapeutics PBC BiotechnologyHealth Technology Part of Multidisciplinary Association for Psychedelic Studies, Lykos Therapeutics, Inc. is a public benefit corporation that focuses on developing and commercializing prescription psychedelics to provide better treatments for people with mental health conditions. The private company is based in San Jose, CA. Lykos Therapeutics aims to catalyze healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics, prioritizing public benefit above profit. The company was founded in 2014, and the CEO is Amy Emerson. | Health Technology |
| The Boston Consulting Group |
